- What is the Laboratory Flexible Funding Model Cooperative Agreement Program?
- What are its goals?
- Who are the current awardees?
- What are the types of assessments?
- Who can I contact for more information?
- Laboratory Flexible Funding Model Cooperative Agreement Program Fact Sheet (Version July 2021)
This cooperative agreement is intended to enhance the capacity and capabilities of state human and animal feed testing laboratories in support of an integrated food safety system. Specifically, through sample testing in the areas of microbiology, chemistry, and radiochemistry, and the development of special projects that would support and expand that testing.
This project will strengthen FDA's efforts to minimize foodborne exposures and prevent foodborne illness through equipping our partner laboratories with additional resources to increase sample throughput capacity within their state. This enhanced proficiency will drive a risk-based and prevention-focused food safety system that both the FDA and our state partners can utilize.
Samples analyzed under this cooperative agreement could derive from a variety of sources including but not limited to: an approved sample plan, emergency outbreak situations, national special security exercises, or an FDA assignment. Laboratories may be requested to participate in national special security exercises and FDA assignments. Samples may also be collected by other organizations (e.g., FDA or a 3rd party) and submitted to participating laboratories for analysis.
The major goals of this program are to:
- Improve human and animal food testing surveillance programs.
- Enhance the network capacity of state laboratories by using sample testing in the areas of microbiology, chemistry, and radiochemistry, and the development of special projects.
- Expand the national capacity in scientific technology and other areas of interest.
- Accelerate foodborne illness outbreak investigations and reduce foodborne illnesses and deaths.
- Utilize sample data generated by these laboratories to remove adulterated food from commerce and aide regulatory programs in conducting inspections.
- Develop methods for early identification of emerging issues, monitoring and evaluation for future sampling initiatives.
- Monitor circulating SARS-CoV-2 variants of concern in populations with high percentages of agricultural and/or food facility workers in alignment with the 21 FORWARD platform. Funding for this project is specific to year 2 only.
United States map displaying 40 FDA funded Laboratory Flexible Funding Model cooperative agreement states:
- There are 55 state programs currently enrolled: AK; AZ; AR; CA*; CO*; CT; FL*; GA; HI; IA*; IL; IN*; KS; KY; LA; MA; MD; MI*; MN*; MO; MS; NC*; NE; NH; NJ*; NM; NV; NY*; OH; PA*; RI; SC; SD; TN; TX*; VA; VT; WA*; WI*; WV
- CA, CO, FL, IA, IN, MI, MN, NC, NJ, NY, PA, TX, WA, and WI each have 2 or more agencies with Lab FFM cooperative agreements
- Microbiology Assessment - Analytical Track 1: Food Defense
- Microbiology Assessment - Analytical Track 2: Human Food Product and Environmental Testing
- Microbiology Assessment - Analytical Track 3: Animal Food Product and Environmental Testing
- Microbiology Assessment - Analytical Track 4: Whole Genome Sequencing
- Chemistry Assessment - Analytical Tracks 1-3
- Radiochemistry Assessment - Analytical Track 1: Food Defense
The first technical session for this program was held on February 24, 2020. Materials from this session include:
- PowerPoint Presentation (LFFM Technical Session_2.24.20)
- Questions and Answers Document (PAR-20-105 Chat Questions and Answers - V1.1)
Specific questions on this program can be directed to the appropriate Office of Partnerships' contact within the Division of Partnership Investments and Agreements. Please visit the Office of Partnerships Contacts webpage to obtain a downloaded version of the staffing roster.
You can also find contact information and more on the funding opportunity announcement.
General questions can be directed to the Office of Partnerships' general mailbox: email@example.com.